Information Regarding Modification of Oral Solid Medicines in Written Drug Information : Potential Consequences for Patient Safety

dc.contributor.author	Zeiss, Daniel Horst
dc.contributor.author	Amundstuen, Linda
dc.date.accessioned	2022-12-06T10:06:37Z
dc.date.available	2022-12-06T10:06:37Z
dc.date.created	2022-11-10T10:23:06Z
dc.date.issued	2022
dc.identifier.citation	Zeiss, D. H. & Amundstuen, L. (2022). Information Regarding Modification of Oral Solid Medicines in Written Drug Information: Potential Consequences for Patient Safety. In R. M. Olsen & H. Sletvold (Eds.), Medication Safety in Municipal Health and Care Services (p. 91–111). Cappelen Damm Akademisk.	en_US
dc.identifier.isbn	9788202738792
dc.identifier.uri	https://hdl.handle.net/11250/3036054
dc.language.iso	eng	en_US
dc.publisher	Cappelen Damm Akademisk	en_US
dc.relation.ispartof	Medication safety in municipal health and care services
dc.rights	Navngivelse 4.0 Internasjonal	*
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/deed.no	*
dc.title	Information Regarding Modification of Oral Solid Medicines in Written Drug Information : Potential Consequences for Patient Safety	en_US
dc.title.alternative	Information Regarding Modification of Oral Solid Medicines in Written Drug Information: Potential Consequences for Patient Safety	en_US
dc.type	Chapter	en_US
dc.type	Peer reviewed	en_US
dc.description.version	publishedVersion	en_US
dc.rights.holder	© 2022 The Author(s)	en_US
dc.source.pagenumber	91-111	en_US
dc.identifier.cristin	2071606

Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal